Research summary
- Open access 0%
- Mean RCR 1.3 — 1.0 = NIH-funded average; biomedical (PMID) works only · mean over 1 works with RCR · small sample — interpret with caution
- 1 Publications
- 3 Datasets & Software
- 1 Patents
PositionsPositions
- PhD Candidate2024–presentGraduate School of Medicine · Nagoya University
- Senior Pharmacologist2016–2024Department of Pharmacology · Centre Hospitalier Universitaire de Caen Normandie
EducationEducation
- Master of Public health in Biostatistics2023–2024Medicine · University of Paris-Saclay
- Postgraduate Diploma in Pharmacology (equivalent to Board certification)2016–2018Medicine · University of Caen Normandy
- Master of Toxicology2017–2018Pharmacy · Université Paris Descartes
- PharmD (Hospital Pharmacy)2007–2016Pharmacy · University of Caen Normandy
PublicationsPublications
- Desaunay, P., Eslier, M., Alexandre, J., Dreyfus, M., Chrétien, B., & Guenolé, F. (2024). Antidepressants and fetal death: A systematic review and disproportionality analysis in the WHO safety database (VigiBaseⓇ). Psychiatry Research, 339, 116048–116048. https://doi.org/10.1016/j.psychres.2024.1160488 citations
Datasets & SoftwareDatasets & Software
- Dolladille, C., CHRETIEN, B., Normandie, C. H. U. D. C., & Normandie, U. D. C. Vigicaen: A vigibase® Pharmacovigilance Database Toolbox.. Zenodo (2026) [Software]. https://doi.org/10.5281/zenodo.21840168
- Chrétien, B. SigmaCV. Zenodo (2026) [Software]. https://doi.org/10.5281/zenodo.20594123
- Chretien, B. Open Editors Plus 2026: Editorial Board Composition of 15,000+ Academic Journals. Zenodo (2026) [Dataset]. https://doi.org/10.5281/zenodo.19468382
Pre-registrationsPre-registrations
- Chrétien, B. (2026). SigmaCV — disambiguation & CV norms. In Open MIND. https://doi.org/10.17605/osf.io/jtgnbOAfirst, corresponding0 citationsFull text
Abstract
This is the preregistration of an observational study examining how researchers are represented in open scholarly data and how they present themselves on academic CVs. It uses SigmaCV, an open-source web application that auto-generates academic CVs from open research data (OpenAlex, ORCID, Crossref, and related sources). Study A (disambiguation error) quantifies how often works automatically attributed to a researcher by open data sources are false positives — not actually theirs — based on participant adjudication, and estimates how correcting these false positives changes the h-index. Study B (metric-display norms) examines whether, when metric display is opt-in with a default of "none," researchers who display any metric choose the h-index more often than field-normalised indicators. The design is a non-interventional secondary analysis of consent-based, pseudonymised platform data from a single worldwide cohort of consenting adult (18+) SigmaCV users; the two studies share one participant pool and one consent. This preregistration fixes only the two confirmatory hypotheses (H1-A, H1-B) and their analyses; all other analyses (predictors of error, name-script and surname-commonness equity, predictive models, latent CV-style classes, biomedical-subgroup descriptives) are exploratory and reported with effect sizes and confidence intervals. Expected outcomes: a participant-adjudicated false-positive attribution rate and its effect on the h-index (with a reference-standard validation substudy and quantitative bias analysis), and the distribution of metric-display choices under an opt-in/default-none regime. Reporting follows STROBE; de-identified, aggregate data and analysis code will be shared consistent with consent. Ethics review is underway at the Nagoya University Graduate School of Medicine Bioethics Review Committee (observational-research panel; pre-review no. CRE-2026-255); data collection begins only after approval.
Grants & FundingGrants & Funding
- Machine Learning-Driven Adaptive Problem Based Learning in Psychopharmacology: A Fra nco-Japanese Cross-Cultural Collaboration for Optimizing Medical Education, Nagoya Daigaku (2025–2029)
- PARANAC, University of Caen Normandy
PatentsPatents
- COMBINATIONS OF ACETAMINOPHEN AND N-ACETYL CYSTEINE FOR THE TREATMENT OF PAIN AND FEVER, CENTRE HOSPITALIER UNIV DE CAEN NORMANDIE [FR] (2023) [EP4238559]
Peer ReviewPeer Review
- Naunyn-Schmiedeberg s Archives of Pharmacology — 26 reviews
- Scientific Reports — 15 reviews
- BMC Pharmacology and Toxicology — 14 reviews
- European Journal of Clinical Pharmacology — 4 reviews
- DARU Journal of Pharmaceutical Sciences — 4 reviews
- Cardiovascular Toxicology — 2 reviews
- BMC Oral Health — 2 reviews
- BMC Endocrine Disorders — 2 reviews
- Clinical Nutrition ESPEN — 2 reviews
- Therapeutic Advances in Psychopharmacology — 2 reviews
- British Journal of Clinical Pharmacology — 2 reviews
- PLoS ONE — 2 reviews
- BMC Psychiatry — 3 reviews
- BMC Ophthalmology — 1 review
- BMC Gastroenterology — 1 review
- Lung — 1 review
- Archives of Dermatological Research — 1 review
- Cell Biology and Toxicology — 1 review
- Discover Medicine — 1 review
- Egyptian Pediatric Association Gazette — 1 review
- Clinical Therapeutics — 1 review
- Translational Psychiatry — 1 review
- Therapeutic Innovation & Regulatory Science — 1 review
- Communications Medicine — 1 review
- World Journal of Surgical Oncology — 1 review
- BMC Neurology — 1 review
- BMC Cancer — 1 review
- BMC Pediatrics — 1 review
- American Journal of Clinical Dermatology — 1 review
- BMC Pregnancy and Childbirth — 1 review
- Clinical Drug Investigation — 1 review